-
6
-
-
84902810936
-
-
Stellungnahme der Bundesärztekammer, der Kassenärztlichen Bundesvereinigung und der Arzneimittelkommission der deutschen Ärzteschaft zu den Anträgen der Fraktion Bündnis 90/Die Grünen, und der Fraktion Die Linke "Cannabis zur medizinischen Behandlung freigeben" vom 25.06.2008. Ausschussdrucksache 16(14)0420(9). Deutscher Bundestag, Ausschuss für Gesundheit
-
Stellungnahme der Bundesärztekammer, der Kassenärztlichen Bundesvereinigung und der Arzneimittelkommission der deutschen Ärzteschaft zu den Anträgen der Fraktion Bündnis 90/Die Grünen "Medizinische Verwendung von Cannabis erleichtern" vom 27. 11. 2007 und der Fraktion Die Linke "Cannabis zur medizinischen Behandlung freigeben" vom 25.06.2008. Ausschussdrucksache 16(14)0420(9). Deutscher Bundestag, Ausschuss für Gesundheit.
-
(2007)
Medizinische Verwendung von Cannabis Erleichtern
, vol.27
, Issue.11
-
-
-
8
-
-
33947489961
-
Isolation, structure, and partial synthesis of an active constituent of hashish
-
Gaoni Y, Mechoulam R: Isolation, structure, and partial synthesis of an active constituent of hashish. J Am Chem Soc 1964; 86: 1646-7.
-
(1964)
J Am Chem Soc
, vol.86
, pp. 1646-1647
-
-
Gaoni, Y.1
Mechoulam, R.2
-
9
-
-
65449146377
-
Emerging strategies for exploiting cannabinoid receptor agonists as medicines
-
Pertwee RG: Emerging strategies for exploiting cannabinoid receptor agonists as medicines. Br J Pharmacol 2009; 156: 397-411.
-
(2009)
Br J Pharmacol
, vol.156
, pp. 397-411
-
-
Pertwee, R.G.1
-
12
-
-
78650120798
-
Cannabinoid receptors and their ligands: Beyond CB1 and CB2
-
Pertwee RG, Howlett AC, Abood ME, et al.: Cannabinoid receptors and their ligands: beyond CB1 and CB2. Pharmacol Rev 2010; 62: 588-631.
-
(2010)
Pharmacol Rev
, vol.62
, pp. 588-631
-
-
Pertwee, R.G.1
Howlett, A.C.2
Abood, M.E.3
-
13
-
-
77954175115
-
Cannabinoid activation of peroxisome proliferator-activated receptors: Potential for modulation of inflammatory disease
-
O'Sullivan SE, Kendall DA: Cannabinoid activation of peroxisome proliferator-activated receptors: potential for modulation of inflammatory disease. Immunobiology 2010; 215: 611-6.
-
(2010)
Immunobiology
, vol.215
, pp. 611-616
-
-
O'sullivan, S.E.1
Kendall, D.A.2
-
14
-
-
34548498839
-
The toxicology of cannabis and cannabis prohibition
-
Grotenhermen F: The toxicology of cannabis and cannabis prohibi - tion. Chem Biodivers 2007; 4: 1744-69.
-
(2007)
Chem Biodivers
, vol.4
, pp. 1744-1769
-
-
Grotenhermen, F.1
-
15
-
-
0038382242
-
Non-acute (residual) neurocognitive effects of cannabis use: A meta-analytic study
-
Grant I, Gonzalez R, Carey CL, Natarajan L, Wolfson T: Non-acute (residual) neurocognitive effects of cannabis use: a meta-analytic study. J Int Neuropsychol Soc 2003; 9: 679-89.
-
(2003)
J Int Neuropsychol Soc
, vol.9
, pp. 679-689
-
-
Grant, I.1
Gonzalez, R.2
Carey, C.L.3
Natarajan, L.4
Wolfson, T.5
-
16
-
-
0037069251
-
Dose-related neurocognitive effects of marijuana use
-
Bolla KI, Brown K, Eldreth D, Tate K, Cadet JL: Dose-related neurocognitive effects of marijuana use. Neurology 2002; 59: 1337-43.
-
(2002)
Neurology
, vol.59
, pp. 1337-1343
-
-
Bolla, K.I.1
Brown, K.2
Eldreth, D.3
Tate, K.4
Cadet, J.L.5
-
17
-
-
34447619511
-
Cannabis use and risk of psychotic or affective mental health outcomes: A systematic review
-
Moore TH, Zammit S, Lingford-Hughes A, et al.: Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 2007; 370: 319-28.
-
(2007)
Lancet
, vol.370
, pp. 319-328
-
-
Moore, T.H.1
Zammit, S.2
Lingford-Hughes, A.3
-
18
-
-
38649131428
-
Daily cannabis use: A novel risk factor of steatosis severity in patients with chronic hepatitis C
-
Hézode C, Zafrani ES, Roudot-Thoraval F, et al.: Daily cannabis use: a novel risk factor of steatosis severity in patients with chronic hepatitis C. Gastroenterology 2008; 134: 432-9.
-
(2008)
Gastroenterology
, vol.134
, pp. 432-439
-
-
Hézode, C.1
Zafrani, E.S.2
Roudot-Thoraval, F.3
-
19
-
-
36749069565
-
A within-subject comparison of withdrawal symptoms during abstinence from cannabis, tobacco, and both substances
-
Vandrey RG, Budney AJ, Hughes JR, Liguori A: A within-subject comparison of withdrawal symptoms during abstinence from cannabis, tobacco, and both substances. Drug Alcohol Depend 2008; 92: 48-54.
-
(2008)
Drug Alcohol Depend
, vol.92
, pp. 48-54
-
-
Vandrey, R.G.1
Budney, A.J.2
Hughes, J.R.3
Liguori, A.4
-
20
-
-
8544278893
-
Long-term efficacy and safety of dronabinol for acquired immunodeficiency syndrome-associated anorexia
-
Beal JE, Olson R, Lefkowitz L, et al.: Long-term efficacy and safety of dronabinol for acquired immunodeficiency syndrome-associated anorexia. J Pain Symptom Manage 1997; 14: 7-14.
-
(1997)
J Pain Symptom Manage
, vol.14
, pp. 7-14
-
-
Beal, J.E.1
Olson, R.2
Lefkowitz, L.3
-
21
-
-
0037040369
-
The effects of cannabinoids on the pharmacokinetics of indinavir and nelfinavir
-
Kosel BW, Aweeka FT, Benowitz NL, et al.: The effects of cannabinoids on the pharmacokinetics of indinavir and nelfinavir. AIDS 2002; 16: 543-50.
-
(2002)
AIDS
, vol.16
, pp. 543-550
-
-
Kosel, B.W.1
Aweeka, F.T.2
Benowitz, N.L.3
-
22
-
-
34147104462
-
Medicinal cannabis does not influence the clinical pharmacokinetics of irinotecan and docetaxel
-
Engels FK, de Jong FA, Sparreboom A, et al.: Medicinal cannabis does not influence the clinical pharmacokinetics of irinotecan and docetaxel. Oncologist 2007; 12: 291-300.
-
(2007)
Oncologist
, vol.12
, pp. 291-300
-
-
Engels, F.K.1
De Jong, F.A.2
Sparreboom, A.3
-
23
-
-
0345668786
-
Interactions of marihuana and 9-THC with other drugs
-
Nahas G, Sutin KM, Harvey DJ, Agurell S (eds.). Totowa, NJ: Humana Press
-
Hollister LE: Interactions of marihuana and 9-THC with other drugs. In: Nahas G, Sutin KM, Harvey DJ, Agurell S (eds.): Marihuana and Medicine. Totowa, NJ: Humana Press 1999: 273-7.
-
(1999)
Marihuana and Medicine
, pp. 273-277
-
-
Hollister, L.E.1
-
25
-
-
0037076468
-
Safety, tolerability, and efficacy of orally administered cannabinoids in MS
-
Killestein J, Hoogervorst EL, Reif M, et al.: Safety, tolerability, and efficacy of orally administered cannabinoids in MS. Neurology 2002; 58: 1404-7.
-
(2002)
Neurology
, vol.58
, pp. 1404-1407
-
-
Killestein, J.1
Hoogervorst, E.L.2
Reif, M.3
-
26
-
-
0242654882
-
Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): Multicentre randomised placebo-controlled trial
-
Zajicek J, Fox P, Sanders H, et al.: Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial. Lancet 2003; 362: 1517-26.
-
(2003)
Lancet
, vol.362
, pp. 1517-1526
-
-
Zajicek, J.1
Fox, P.2
Sanders, H.3
-
27
-
-
70449533773
-
Lack of effect of cannabisbased treatment on clinical and laboratory measures in multiple sclerosis
-
Centonze D, Mori F, Koch G, et al.: Lack of effect of cannabisbased treatment on clinical and laboratory measures in multiple sclerosis. Neurol Sci 2009; 30: 531-4.
-
(2009)
Neurol Sci
, vol.30
, pp. 531-534
-
-
Centonze, D.1
Mori, F.2
Koch, G.3
-
28
-
-
0019604277
-
Treatment of human spasticity with 9-tetrahydrocannabinol
-
Petro DJ, Ellenberger C: Treatment of human spasticity with 9-tetrahydrocannabinol. J Clin Pharmacol 1981; (Suppl 21): 413-6.
-
(1981)
J Clin Pharmacol
, Issue.SUPPL. 21
, pp. 413-416
-
-
Petro, D.J.1
Ellenberger, C.2
-
29
-
-
0023465839
-
Δ9-THC in the treatment of spasticity associated with multiple sclerosis
-
Ungerleider JT, Andyrsiak T, Fairbanks L, Ellison GW, Myers LW: Δ9-THC in the treatment of spasticity associated with multiple sclerosis. Adv Alcohol Substance Abuse 1987; 7: 39-50.
-
(1987)
Adv Alcohol Substance Abuse
, vol.7
, pp. 39-50
-
-
Ungerleider, J.T.1
Andyrsiak, T.2
Fairbanks, L.3
Ellison, G.W.4
Myers, L.W.5
-
30
-
-
28144454955
-
Cannabinoids in multiple sclerosis (CAMS) study: Safety and efficacy data for 12 months follow up
-
Zajicek JP, Sanders HP, Wright DE, et al.: Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up. J Neurol Neurosurg Psychiatry 2005; 76: 1664-9.
-
(2005)
J Neurol Neurosurg Psychiatry
, vol.76
, pp. 1664-1669
-
-
Zajicek, J.P.1
Sanders, H.P.2
Wright, D.E.3
-
31
-
-
4344571664
-
Efficacy, safety and tolerability of an orally administered cannabis extract in the treatment of spasticity in patients with multiple sclerosis: A randomized, double-blind, placebo-controlled, crossover study
-
Vaney C, Heinzel-Gutenbrunner M, Jobin P, et al.: Efficacy, safety and tolerability of an orally administered cannabis extract in the treatment of spasticity in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled, crossover study. Multiple Sclerosis 2004; 10: 417-24.
-
(2004)
Multiple Sclerosis
, vol.10
, pp. 417-424
-
-
Vaney, C.1
Heinzel-Gutenbrunner, M.2
Jobin, P.3
-
32
-
-
4344582253
-
Do cannabis- based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients
-
Wade DT, Makela P, Robson P, House H, Bateman C: Do cannabis- based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients. Mult Scler 2004; 10: 434-41.
-
(2004)
Mult Scler
, vol.10
, pp. 434-441
-
-
Wade, D.T.1
Makela, P.2
Robson, P.3
House, H.4
Bateman, C.5
-
33
-
-
33745025055
-
Longterm use of a cannabis-based medicine in the treatment of spasticity and other symptoms in multiple sclerosis
-
Wade DT, Makela PM, House H, Bateman C, Robson P: Longterm use of a cannabis-based medicine in the treatment of spasticity and other symptoms in multiple sclerosis. Mult Scler 2006; 12: 639-45.
-
(2006)
Mult Scler
, vol.12
, pp. 639-645
-
-
Wade, D.T.1
Makela, P.M.2
House, H.3
Bateman, C.4
Robson, P.5
-
34
-
-
33847766180
-
For the Sativex Spasticity in MS Study Group: Randomized controlled trial of cannabis-based medicine in spasticity caused by multiple sclerosis
-
Collin C, Davies P, Mutiboko IK, Ratcliffe S, for the Sativex Spasticity in MS Study Group: Randomized controlled trial of cannabis-based medicine in spasticity caused by multiple sclerosis. Eur J Neurology 2007; 14: 290-6.
-
(2007)
Eur J Neurology
, vol.14
, pp. 290-296
-
-
Collin, C.1
Davies, P.2
Mutiboko, I.K.3
Ratcliffe, S.4
-
35
-
-
63549096654
-
Cannabinoid-induced effects on the nociceptive system: A neurophysiological study in patients with secondary progressive multiple sclerosis
-
Conte A, Bettolo CM, Onesti E, et al.: Cannabinoid-induced effects on the nociceptive system: a neurophysiological study in patients with secondary progressive multiple sclerosis. Eur J Pain 2009; 13: 472-7.
-
(2009)
Eur J Pain
, vol.13
, pp. 472-477
-
-
Conte, A.1
Bettolo, C.M.2
Onesti, E.3
-
36
-
-
79953822342
-
A randomized, doubleblind, placebo-controlled, parallel-group, enriched-design study of nabiximols (Sativex), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis
-
Novotna A, Mares J, Ratcliffe S, et al.: A randomized, doubleblind, placebo-controlled, parallel-group, enriched-design study of nabiximols (Sativex), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis. Eur J Neurol 2011; 18: 1122-31.
-
(2011)
Eur J Neurol
, vol.18
, pp. 1122-1131
-
-
Novotna, A.1
Mares, J.2
Ratcliffe, S.3
-
38
-
-
34547623372
-
The treatment of spasticity with delta-9-tetrahydrocannabinol in persons with spinal cord injury
-
Hagenbach U, Luz S, Ghafoor N, et al.: The treatment of spasticity with delta-9-tetrahydrocannabinol in persons with spinal cord injury. Spinal Cord 2007; 45: 551-62.
-
(2007)
Spinal Cord
, vol.45
, pp. 551-562
-
-
Hagenbach, U.1
Luz, S.2
Ghafoor, N.3
-
39
-
-
77951262920
-
A randomized, double-blinded, crossover pilot study assessing the effect of nabilone on spasticity in persons with spinal cord injury
-
Pooyania S, Ethans K, Szturm T, Casey A, Perry D: A randomized, double-blinded, crossover pilot study assessing the effect of nabilone on spasticity in persons with spinal cord injury. Arch Phys Med Rehabil 2010; 91: 703-7.
-
(2010)
Arch Phys Med Rehabil
, vol.91
, pp. 703-707
-
-
Pooyania, S.1
Ethans, K.2
Szturm, T.3
Casey, A.4
Perry, D.5
-
40
-
-
84902824406
-
Tetrahydrocannabinol (THC) plus prochlorperazine (PCZ) for refractory nausea and vomiting (N/V)
-
Artim R, DiBella N: Tetrahydrocannabinol (THC) plus prochlorperazine (PCZ) for refractory nausea and vomiting (N/V). Proc Am Soc Clin Oncol 1983; 2: 84.
-
(1983)
Proc Am Soc Clin Oncol
, vol.2
, pp. 84
-
-
Artim, R.1
Dibella, N.2
-
41
-
-
0018653395
-
Delta-9-tetrahydrocannabinol as an antiemetics in cancer patients receiving high-dose methotrexate
-
Chang AE, Shiling DJ, Stillman RC, Goldberg NH, Seipp CA, Barofsky I: Delta-9-tetrahydrocannabinol as an antiemetics in cancer patients receiving high-dose methotrexate. Ann Int Med 1979; 91: 819-24.
-
(1979)
Ann Int Med
, vol.91
, pp. 819-824
-
-
Chang, A.E.1
Shiling, D.J.2
Stillman, R.C.3
Goldberg, N.H.4
Seipp, C.A.5
Barofsky, I.6
-
42
-
-
0019460943
-
A prospective evaluation of delta-9-tetrahydrocannabinol as an antiemetic in patients receiving adriamycin and cytoxan chemotherapy
-
Chang AE, Shiling DJ, Stillman RC, et al.: A prospective evaluation of delta-9-tetrahydrocannabinol as an antiemetic in patients receiving adriamycin and cytoxan chemotherapy. Cancer 1981; 47: 1746-51.
-
(1981)
Cancer
, vol.47
, pp. 1746-1751
-
-
Chang, A.E.1
Shiling, D.J.2
Stillman, R.C.3
-
43
-
-
0018828574
-
The antiemetic activity of tetrahydrocanabinol versus metoclopramide and thiethylperazine in patients undergoing cancer chemotherapy
-
Colls BM, Ferry DG, Gray AJ, Harvey VJ, McQueen EG: The antiemetic activity of tetrahydrocanabinol versus metoclopramide and thiethylperazine in patients undergoing cancer chemotherapy. N Z Med J 1980; 91: 449-51.
-
(1980)
N Z Med J
, vol.91
, pp. 449-451
-
-
Colls, B.M.1
Ferry, D.G.2
Gray, A.J.3
Harvey, V.J.4
McQueen, E.G.5
-
44
-
-
0018793008
-
Amelioration of cancer chemotherapy-induced nausea and vomiting by Δ9-tetrahydrocannabinol
-
Ekert H, Waters KD, Jurk KH, Mobilia J, Loughnan P: Amelioration of cancer chemotherapy-induced nausea and vomiting by Δ9- tetrahydrocannabinol. Med J Aust 1979; 2: 657-9.
-
(1979)
Med J Aust
, vol.2
, pp. 657-659
-
-
Ekert, H.1
Waters, K.D.2
Jurk, K.H.3
Mobilia, J.4
Loughnan, P.5
-
45
-
-
0018611443
-
Delta-9-tetrahydrocannabinol as an antiemetics for patients receiving cancer chemotherapy. A comparison with prochlorperazine and a placebo
-
Frytak S, Moertel CG, O'Fallon JR, Rubin J, Creagan ET, O'Connnell MJ: Delta-9-tetrahydrocannabinol as an antiemetics for patients receiving cancer chemotherapy. A comparison with prochlorperazine and a placebo. Ann Int Med 1979; 91: 825-30.
-
(1979)
Ann Int Med
, vol.91
, pp. 825-830
-
-
Frytak, S.1
Moertel, C.G.2
O'fallon, J.R.3
Rubin, J.4
Creagan, E.T.5
O'connnell, M.J.6
-
46
-
-
0021356476
-
Antiemetic therapy: A review of recent studies and a report of a random assignment trial comparing metoclopramide with delta-9-tetrahydrocannabinol
-
Gralla RJ, Tyson LB, Bordin LA, Clark RA, Kelsen DP, Kris MG: Antiemetic therapy: a review of recent studies and a report of a random assignment trial comparing metoclopramide with delta-9-tetrahydrocannabinol. Can Treat Rep 1984; 68: 163-72.
-
(1984)
Can Treat Rep
, vol.68
, pp. 163-172
-
-
Gralla, R.J.1
Tyson, L.B.2
Bordin, L.A.3
Clark, R.A.4
Kelsen, D.P.5
Kris, M.G.6
-
47
-
-
0018668244
-
Δ9-tetrahydrocannabinol (THC) as an antiemetic in patients treated with cancer chemotherapy; A double-blind crossover trial against placebo
-
Kluin-Nelemans JC, Nelemans FA, Meuwissen OJATh, Maes RAA: Δ9-tetrahydrocannabinol (THC) as an antiemetic in patients treated with cancer chemotherapy; a double-blind crossover trial against placebo. Vet Hum Toxicol 1979; 21: 338-40.
-
(1979)
Vet Hum Toxicol
, vol.21
, pp. 338-340
-
-
Kluin-Nelemans, J.C.1
Nelemans, F.A.2
Meuwissen Th., O.J.A.3
Maes, R.A.A.4
-
48
-
-
0026212048
-
Dronabinol and prochlorperazine in combination for treatment of cancer chemotherapy-induced nausea and vomiting
-
Lane M, Vogel CL, Ferguson J, Krasnow S, Saiers JL, Hamm J: Dronabinol and prochlorperazine in combination for treatment of cancer chemotherapy-induced nausea and vomiting. J Pain Sym Manag 1991; 6: 352-9.
-
(1991)
J Pain Sym Manag
, vol.6
, pp. 352-359
-
-
Lane, M.1
Vogel, C.L.2
Ferguson, J.3
Krasnow, S.4
Saiers, J.L.5
Hamm, J.6
-
49
-
-
0003376856
-
Randomized double blind comparison of delta-9-tetrahydroicannabinol (THC) and marijuana as chemotherapy antiemetics
-
Levitt M, Faiman C, Hawks R, Wilson A: Randomized double blind comparison of delta-9-tetrahydroicannabinol (THC) and marijuana as chemotherapy antiemetics. Proc Am Soc Clin Oncol 1984; 3: 91.
-
(1984)
Proc Am Soc Clin Oncol
, vol.3
, pp. 91
-
-
Levitt, M.1
Faiman, C.2
Hawks, R.3
Wilson, A.4
-
50
-
-
84902763519
-
Dose vs response of tetrahydroannabinol (THC) vs prochlorperazine as chemotherapy antiemetics
-
Levitt M, Wilson A, Bowman D, Faiman C, Kemel S, Krepart G: Dose vs response of tetrahydroannabinol (THC) vs prochlorperazine as chemotherapy antiemetics. Proc Am Soc Clin Oncol 1981; 22: 422.
-
(1981)
Proc Am Soc Clin Oncol
, vol.22
, pp. 422
-
-
Levitt, M.1
Wilson, A.2
Bowman, D.3
Faiman, C.4
Kemel, S.5
Krepart, G.6
-
51
-
-
0023705667
-
Efficacy of tetrahydrocannabinol in patients refractory to standard anti-emetic therapy
-
McCabe M, Smith FP, Goldberg D, Macdonald J, Woolley PV, Warren R: Efficacy of tetrahydrocannabinol in patients refractory to standard anti-emetic therapy. Invest New Drugs 1988; 6: 243-6.
-
(1988)
Invest New Drugs
, vol.6
, pp. 243-246
-
-
McCabe, M.1
Smith, F.P.2
Goldberg, D.3
MacDonald, J.4
Woolley, P.V.5
Warren, R.6
-
53
-
-
0018969807
-
Antiemetic effect of tetrahydrocannabinol compared with placebo and prochlorperazine in chemotherapy-associated nausea and emesis
-
Orr LE, McKernan JF, Bloome B: Antiemetic effect of tetrahydrocannabinol. Compared with placebo and prochlorperazine in chemotherapy-associated nausea and emesis. Arch Int Med 1980; 140: 1431-33.
-
(1980)
Arch Int Med
, vol.140
, pp. 1431-1433
-
-
Orr, L.E.1
McKernan, J.F.2
Bloome, B.3
-
54
-
-
0018922982
-
Antiemetics in patients receiving chemotherapy for cancer. A randomized comparison of delta-9-tetrahydrocannabinol and prochlorperazine
-
Sallan SE, Cronin C, Zelen M, Zinberg NE: Antiemetics in patients receiving chemotherapy for cancer. A randomized comparison of delta-9-tetrahydrocannabinol and prochlorperazine. N Engl J Med 1980; 302: 135-8.
-
(1980)
N Engl J Med
, vol.302
, pp. 135-138
-
-
Sallan, S.E.1
Cronin, C.2
Zelen, M.3
Zinberg, N.E.4
-
55
-
-
0016801115
-
Antiemetic effect of delta-9-tetrahydrocannabinol in patients receiving cancer chemotherapy
-
Sallan SE, Zinberg NE, Frei E: Antiemetic effect of delta-9- tetrahydrocannabinol in patients receiving cancer chemotherapy. N Engl J Med 1975; 293: 795-7.
-
(1975)
N Engl J Med
, vol.293
, pp. 795-797
-
-
Sallan, S.E.1
Zinberg, N.E.2
Frei, E.3
-
56
-
-
0019950055
-
Cannabis and cancer chemotherapy. A comparison of oral delta-9-THC and prochlorperazine
-
Ungerleider JT, Andrysiak T, Fairbanks L, Goodnight J, Sarna G, Jamison K: Cannabis and cancer chemotherapy. A comparison of oral delta-9-THC and prochlorperazine. Cancer 1982; 50: 636-45.
-
(1982)
Cancer
, vol.50
, pp. 636-645
-
-
Ungerleider, J.T.1
Andrysiak, T.2
Fairbanks, L.3
Goodnight, J.4
Sarna, G.5
Jamison, K.6
-
57
-
-
0021932252
-
THC or compazine for the cancer chemotherapy patient - The UCLA study. Part II: Patient drug preference
-
Ungerleider JT, Sarna G, Fairbanks LA, Goodnight J, Andrysiak T, Jamison K: THC or compazine for the cancer chemotherapy patient - the UCLA study. Part II: patient drug preference. Am J Clin Oncol 1985; 8: 142-7.
-
(1985)
Am J Clin Oncol
, vol.8
, pp. 142-147
-
-
Ungerleider, J.T.1
Sarna, G.2
Fairbanks, L.A.3
Goodnight, J.4
Andrysiak, T.5
Jamison, K.6
-
58
-
-
33947356563
-
Efficacy of dronabinol alone and in combination with ondansetron versus ondansetron alone for delayed chemotherapy-induced nausea and vomiting
-
Meiri E, Jhangiani H, Vredenburgh JJ, et al.: Efficacy of dronabinol alone and in combination with ondansetron versus ondansetron alone for delayed chemotherapy-induced nausea and vomiting. Curr Med Res Opin 2007; 23: 533-43.
-
(2007)
Curr Med Res Opin
, vol.23
, pp. 533-543
-
-
Meiri, E.1
Jhangiani, H.2
Vredenburgh, J.J.3
-
59
-
-
78649287164
-
Preliminary efficacy and safety of an oromucosal standardized cannabis extract in chemotherapy-induced nausea and vomiting
-
Duran M, Pérez E, Abanades S, et al.: Preliminary efficacy and safety of an oromucosal standardized cannabis extract in chemotherapy-induced nausea and vomiting. Br J Clin Pharmacol 2010; 70: 656-63.
-
(2010)
Br J Clin Pharmacol
, vol.70
, pp. 656-663
-
-
Duran, M.1
Pérez, E.2
Abanades, S.3
-
60
-
-
0021052856
-
Anti-emetic efficacy and toxicity of nabilone, a synthetic cannabinoid, in lung cancer chemotherapy
-
Ahmedzai S, Carlyle DL, Clader IT, Moran F: Anti-emetic efficacy and toxicity of nabilone, a synthetic cannabinoid, in lung cancer chemotherapy. Br J Cancer 1983; 48: 657-63.
-
(1983)
Br J Cancer
, vol.48
, pp. 657-663
-
-
Ahmedzai, S.1
Carlyle, D.L.2
Clader, I.T.3
Moran, F.4
-
61
-
-
0023266519
-
Nabilone versus prochlorperazine for control of cancer chemotherapy-induced emesis in children: A double-blind, crossover trial
-
Chan HS, Correia JA, MacLeod SM: Nabilone versus prochlorperazine for control of cancer chemotherapy-induced emesis in children: a double-blind, crossover trial. Pediatrics 1987; 79: 946-52.
-
(1987)
Pediatrics
, vol.79
, pp. 946-952
-
-
Chan, H.S.1
Correia, J.A.2
MacLeod, S.M.3
-
62
-
-
0022597720
-
Nabilone and metoclopramide in the treatment of nausea and vomiting due to cisplatinum: A double blind study
-
Crawford SM, Buckman R: Nabilone and metoclopramide in the treatment of nausea and vomiting due to cisplatinum: a double blind study. Med Oncol Tumour Pharmacother 1986; 3: 39-42.
-
(1986)
Med Oncol Tumour Pharmacother
, vol.3
, pp. 39-42
-
-
Crawford, S.M.1
Buckman, R.2
-
63
-
-
0023884902
-
A randomized trial of oral nabilone and prochlorperazine compared to intravenous metoclopramide and dexamethasone in the treatment of nausea and vomiting induced by chemotherapy regimens containing cisplatin or cisplatin analogues
-
Cunningham D, Bradley CJ, Forrest GJ, et al.: A randomized trial of oral nabilone and prochlorperazine compared to intravenous metoclopramide and dexamethasone in the treatment of nausea and vomiting induced by chemotherapy regimens containing cisplatin or cisplatin analogues. Eur J Can Clin Oncol 1988; 24: 685-9.
-
(1988)
Eur J Can Clin Oncol
, vol.24
, pp. 685-689
-
-
Cunningham, D.1
Bradley, C.J.2
Forrest, G.J.3
-
64
-
-
0022610744
-
Nabilone: An alternative antiemetic for cancer chemotherapy
-
Dalzell AM, Bartlett H, Lilleyman JS: Nabilone: An alternative antiemetic for cancer chemotherapy. Arch Dis Child 1986; 61: 502-5.
-
(1986)
Arch Dis Child
, vol.61
, pp. 502-505
-
-
Dalzell, A.M.1
Bartlett, H.2
Lilleyman, J.S.3
-
65
-
-
0019605643
-
Nabilone: An effective antiemetic in patients receiving cancer chemotherapy
-
Einhorn LH, Nagy C, Furnas B, Williams SD: Nabilone: an effective antiemetic in patients receiving cancer chemotherapy. J Clin Pharmacol 1981; 21(8-9 Suppl): 64-9.
-
(1981)
J Clin Pharmacol
, vol.21
, Issue.8-9 SUPPL.
, pp. 64-69
-
-
Einhorn, L.H.1
Nagy, C.2
Furnas, B.3
Williams, S.D.4
-
66
-
-
0020510263
-
Randomized comparative trial of a new antiemetic: Nabilone, in cancer patients treated with cisplatin
-
George M, Pejovic MH, Thuaire M, Kramar A, Wolff JP: Random - ized comparative trial of a new anti-emetic: nabilone, in cancer patients treated with cisplatin. Biomed Pharmacother 1983; 37: 24-7.
-
(1983)
Biomed Pharmacother
, vol.37
, pp. 24-27
-
-
George, M.1
Pejovic, M.H.2
Thuaire, M.3
Kramar, A.4
Wolff, J.P.5
-
67
-
-
0018747577
-
Superiority of nabilone over prochlorperazine as an antiemetic in patients receiving cancer chemotherapy
-
Herman TS, Einhorn LH, Jones SE, et al.: Superiority of nabilone over prochlorperazine as an antiemetic in patients receiving cancer chemotherapy. N Engl J Med 1979; 300: 1295-7.
-
(1979)
N Engl J Med
, vol.300
, pp. 1295-1297
-
-
Herman, T.S.1
Einhorn, L.H.2
Jones, S.E.3
-
68
-
-
0020283655
-
A double-blind, controlled trial of nabilone vs prochlorperazine for refractory emesis induced by cancer chemotherapy
-
Johansson R, Kilkku P, Groenroos M: A double-blind, controlled trial of nabilone vs prochlorperazine for refractory emesis induced by cancer chemotherapy. Can Treat Rev 1982; 9: 25-33.
-
(1982)
Can Treat Rev
, vol.9
, pp. 25-33
-
-
Johansson, R.1
Kilkku, P.2
Groenroos, M.3
-
69
-
-
0020261715
-
A multi-institutional phase III study of nabilone vs placebo in chemotherapy-induced nausea and vomiting
-
Jones SE, Durant JR, Greco FA, Robertone A: A multi-institutional phase III study of nabilone vs placebo in chemotherapy-induced nausea and vomiting. Can Treat Rev 1982; 9: 45-8.
-
(1982)
Can Treat Rev
, vol.9
, pp. 45-48
-
-
Jones, S.E.1
Durant, J.R.2
Greco, F.A.3
Robertone, A.4
-
70
-
-
0020309510
-
Nabilone vs placebo in the treatment of chemotherapyinduced nausea and vomiting in cancer patients
-
Levitt M: Nabilone vs placebo in the treatment of chemotherapyinduced nausea and vomiting in cancer patients. Can Treat Rev 1982; 9(suppl B): 49-53.
-
(1982)
Can Treat Rev
, vol.9
, Issue.SUPPL. B
, pp. 49-53
-
-
Levitt, M.1
-
72
-
-
0022576585
-
Crossover comparison of the antiemetic efficacy of nabilone and alizapride in patients with nonseminomatous testicular cancer receiving cisplatin therapy
-
Niederle N, Schutte J, Schmidt CG: Crossover comparison of the antiemetic efficacy of nabilone and alizapride in patients with nonseminomatous testicular cancer receiving cisplatin therapy. Klin Wochenschr 1986; 64: 362-5.
-
(1986)
Klin Wochenschr
, vol.64
, pp. 362-365
-
-
Niederle, N.1
Schutte, J.2
Schmidt, C.G.3
-
73
-
-
0022371079
-
A cross-over comparison of nabilone and prochlorperazine for emesis induced by cancer chemotherapy
-
Niiranen Aila, Mattson K: A cross-over comparison of nabilone and prochlorperazine for emesis induced by cancer chemotherapy. Am J Clin Oncol 1985; 8: 336-40.
-
(1985)
Am J Clin Oncol
, vol.8
, pp. 336-340
-
-
Aila, N.1
Mattson, K.2
-
74
-
-
0022547598
-
Prospective randomized double-blind trial of nabilone versus domperidone in the treatment of cytotoxic-induced emesis
-
Pomeroy M, Fennelly JJ, Towers M: Prospective randomized double-blind trial of nabilone versus domperidone in the treatment of cytotoxic-induced emesis. Can Chemother Pharmacol 1986; 17: 285-8.
-
(1986)
Can Chemother Pharmacol
, vol.17
, pp. 285-288
-
-
Pomeroy, M.1
Fennelly, J.J.2
Towers, M.3
-
75
-
-
0018899177
-
Double-blind comparison of the antiemetic effects of nabilone and prochlorperazine on chemotherapy-induced emesis
-
Steele N, Gralla RJ, Braun Jr DW, Young CW: Double-blind comparison of the antiemetic effects of nabilone and prochlorperazine on chemotherapy-induced emesis. Can Treat Rep 1980; 64: 219-24.
-
(1980)
Can Treat Rep
, vol.64
, pp. 219-224
-
-
Steele, N.1
Gralla, R.J.2
Braun Jr., D.W.3
Young, C.W.4
-
76
-
-
0020285148
-
Double-blind, randomized, crossover trial of nabilone vs placebo in cancer chemotherapy
-
Wada JK, Bogdon DL, Gunnell JC, Hum GJ, Gota CH, Rieth TE: Double-blind, randomized, crossover trial of nabilone vs. placebo in cancer chemotherapy. Cancer Treatment Rev 1982; 9(Suppl B): 39-44.
-
(1982)
Cancer Treatment Rev
, vol.9
, Issue.SUPPL. B
, pp. 39-44
-
-
Wada, J.K.1
Bogdon, D.L.2
Gunnell, J.C.3
Hum, G.J.4
Gota, C.H.5
Rieth, T.E.6
-
77
-
-
0021913458
-
Antiemetic efficacy of levonantradol compared to delta-9- tetrahydrocannabinol for chemotherapy-induced nausea and vomiting
-
Citron ML, Herman TS, Vreeland F, Krasnow SH, Fossieck BE Jr: Antiemetic efficacy of levonantradol compared to delta-9-tetrahydrocannabinol for chemotherapy-induced nausea and vomiting. Cancer Treat Rep 1985; 69: 109-12.
-
(1985)
Cancer Treat Rep
, vol.69
, pp. 109-112
-
-
Citron, M.L.1
Herman, T.S.2
Vreeland, F.3
Krasnow, S.H.4
Fossieck Jr., B.E.5
-
78
-
-
0019956774
-
Levonantradol bei der Behandlung von zytostatika-bedingter Übelkeit und Erbrechen
-
Higi M, Niederle N, Bremer K, Schmitt G, Schmidt CG, Seeber S: Levonantradol bei der Behandlung von zytostatika-bedingter Übelkeit und Erbrechen. Dtsch Med Wochenschr 1982; 107: 1232-4.
-
(1982)
Dtsch Med Wochenschr
, vol.107
, pp. 1232-1234
-
-
Higi, M.1
Niederle, N.2
Bremer, K.3
Schmitt, G.4
Schmidt, C.G.5
Seeber, S.6
-
79
-
-
0020576410
-
A randomised multicentre single blind comparison of a cannabinoid anti-emetic (levonantradol) with ychlorpromazine in patients receiving their first cytotoxic chemotherapy
-
Hutcheon AW, Palmer JB, Soukop M, et al.: A randomised multicentre single blind comparison of a cannabinoid anti-emetic (levonantradol) with ychlorpromazine in patients receiving their first cytotoxic chemotherapy. Eur J Can Clin Oncol 1983; 19: 1087-90.
-
(1983)
Eur J Can Clin Oncol
, vol.19
, pp. 1087-1090
-
-
Hutcheon, A.W.1
Palmer, J.B.2
Soukop, M.3
-
80
-
-
0021688369
-
Dose ranging evalua - Tion of the antiemetic efficacy and toxicity of intramuscular levonantradol in cancer subjects with chemotherapy-induced emesis
-
Stambaugh Jr JE, McAdams J, Vreeland F: Dose ranging evalua - tion of the antiemetic efficacy and toxicity of intramuscular levonantradol in cancer subjects with chemotherapy-induced emesis. Int J Clin Pharmacol Res 1984; 24: 480-5.
-
(1984)
Int J Clin Pharmacol Res
, vol.24
, pp. 480-485
-
-
Stambaugh Jr., J.E.1
McAdams, J.2
Vreeland, F.3
-
81
-
-
33745515076
-
American society of clinical oncology guideline for antiemetics in oncology: Update 2006
-
American Society of Clinical Oncology
-
American Society of Clinical Oncology, Kris MG, Hesketh PJ, et al.: American Society of Clinical Oncology guideline for antiemetics in oncology: Update 2006 J Clin Oncol 2006; 24 2932-47
-
(2006)
J Clin Oncol
, vol.24
, pp. 2932-2947
-
-
Kris, M.G.1
Hesketh, P.J.2
-
82
-
-
27144517504
-
-
Antiemesis, V.3
-
National Comprehensive Cancer Network: NCCN Clinical Practice Guidelines in Oncology: Antiemesis, V.3.2008. Available at: www.nccn.org/professionals/ physician-gls/PDF/antiemesis.pdf.
-
(2008)
NCCN Clinical Practice Guidelines in Oncology
-
-
-
83
-
-
0027200985
-
Effect of dronabinol on nutritional status in HIV infection
-
Struwe M, Kaempfer SH, Geiger CJ, et al.: Effect of dronabinol on nutritional status in HIV infection. Ann Pharmacother 1993; 27: 827-31.
-
(1993)
Ann Pharmacother
, vol.27
, pp. 827-831
-
-
Struwe, M.1
Kaempfer, S.H.2
Geiger, C.J.3
-
84
-
-
0028935579
-
Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS
-
Beal JE, Olson R, Laubenstein L, et al.: Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS. J Pain Sympt Manag 1995; 10: 89-97.
-
(1995)
J Pain Sympt Manag
, vol.10
, pp. 89-97
-
-
Beal, J.E.1
Olson, R.2
Laubenstein, L.3
-
85
-
-
8044242331
-
The safety and pharmacokinetics of single-agent and combination therapy with megestrol acetate and dronabinol for the treatment of HIV wasting syndrome
-
Timpone JG, Wright DJ, Li N, et al.: The safety and pharmacokinetics of single-agent and combination therapy with megestrol acetate and dronabinol for the treatment of HIV wasting syn - drome. AIDS Res Hum Retroviruses 1997; 13: 305-15.
-
(1997)
AIDS Res Hum Retroviruses
, vol.13
, pp. 305-315
-
-
Timpone, J.G.1
Wright, D.J.2
Li, N.3
-
86
-
-
78651301281
-
Efficacy and tolerability of high-dose dronabinol maintenance in HIV-positive marijuana smokers: A controlled laboratory study
-
Bedi G, Foltin RW, Gunderson EW, et al.: Efficacy and tolerability of high-dose dronabinol maintenance in HIV-positive marijuana smokers: a controlled laboratory study. Psychopharmacology 2010; 212: 675-86.
-
(2010)
Psychopharmacology
, vol.212
, pp. 675-686
-
-
Bedi, G.1
Foltin, R.W.2
Gunderson, E.W.3
-
87
-
-
0141677644
-
Short-term effects of cannabinoids in patients with HIV-1 infection: A randomized, placebo-controlled clinical trial
-
Abrams DI, Hilton JF, Leiser RJ, et al.: Short-term effects of cannabinoids in patients with HIV-1 infection: a randomized, placebo-controlled clinical trial. Ann Intern Med 2003; 139: 258-66.
-
(2003)
Ann Intern Med
, vol.139
, pp. 258-266
-
-
Abrams, D.I.1
Hilton, J.F.2
Leiser, R.J.3
-
88
-
-
26644474134
-
Dronabinol and marijuana in HIV(+) marijuana smokers: Acute effects on caloric intake and mood
-
Haney M, Rabkin J, Gunderson E, Foltin RW: Dronabinol and marijuana in HIV(+) marijuana smokers: acute effects on caloric intake and mood. Psychopharmacology 2005; 181: 170-8.
-
(2005)
Psychopharmacology
, vol.181
, pp. 170-178
-
-
Haney, M.1
Rabkin, J.2
Gunderson, E.3
Foltin, R.W.4
-
89
-
-
34548057495
-
Dronabinol and marijuana in HIV-positive marijuana smokers. Caloric intake, mood, and sleep
-
Haney M, Gunderson EW, Rabkin J, et al.: Dronabinol and marijuana in HIV-positive marijuana smokers. Caloric intake, mood, and sleep. J Acquir Immune Defic Syndr 2007; 45: 545-54.
-
(2007)
J Acquir Immune Defic Syndr
, vol.45
, pp. 545-554
-
-
Haney, M.1
Gunderson, E.W.2
Rabkin, J.3
-
90
-
-
0037080279
-
Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: A North Central Cancer Treatment Group study
-
Jatoi A, Windschitl HE, Loprinzi CL, et al.: Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study. J Clin Oncol 2002; 20: 567-73.
-
(2002)
J Clin Oncol
, vol.20
, pp. 567-573
-
-
Jatoi, A.1
Windschitl, H.E.2
Loprinzi, C.L.3
-
91
-
-
0002135271
-
Delta-9-tetrahydrocannabinol as an effective antidepressant and appetite-stimulating agent in advanced cancer patients
-
Braude MC, Szara S (eds.), New York: Raven Press
-
Regelson W, Butler JR, Schulz J, et al.: Delta-9-tetrahydrocannabinol as an effective antidepressant and appetite-stimulating agent in advanced cancer patients. In: Braude MC, Szara S (eds.): Pharmacology of marihuana. Vol 2. New York: Raven Press 1976; 763-76.
-
(1976)
Pharmacology of Marihuana
, vol.2
, pp. 763-776
-
-
Regelson, W.1
Butler, J.R.2
Schulz, J.3
-
92
-
-
79958253782
-
Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: Results of a randomized, double-blind, placebocontrolled pilot trial
-
Brisbois TD, de Kock IH, Watanabe SM, et al.: Delta-9- tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double-blind, placebocontrolled pilot trial. Ann Oncol 2011; 22: 2086-93.
-
(2011)
Ann Oncol
, vol.22
, pp. 2086-2093
-
-
Brisbois, T.D.1
De Kock, I.H.2
Watanabe, S.M.3
-
93
-
-
33746793870
-
Comparison of orally administered cannabis extract and delta- 9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: A multicenter, phase III, random - Ized, double-blind, placebo-controlled clinical trial from the Cannabis-In-Cachexia- Study-Group
-
Cannabis-In-Cachexia-Study-Group, Strasser F, Luftner D, et al.: Comparison of orally administered cannabis extract and delta- 9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, random - ized, double-blind, placebo-controlled clinical trial from the Cannabis-In-Cachexia- Study-Group. J Clin Oncol 2006; 24: 3394-400.
-
(2006)
J Clin Oncol
, vol.24
, pp. 3394-3400
-
-
Strasser, F.1
Luftner, D.2
-
94
-
-
0030886734
-
Effects of dronabinol on anorexia and disturbed behavior in patients with Alzheimer's disease
-
Volicer L, Stelly M, Morris J, McLaughlin J, Volicer BJ: Effects of dronabinol on anorexia and disturbed behavior in patients with Alzheimer's disease. Int J Geriatr Psychiatry 1997; 12: 913-9.
-
(1997)
Int J Geriatr Psychiatry
, vol.12
, pp. 913-919
-
-
Volicer, L.1
Stelly, M.2
Morris, J.3
McLaughlin, J.4
Volicer, B.J.5
-
95
-
-
4043096916
-
Does the cannabinoid dro - Nabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial
-
Svendsen KB, Jensen TS, Bach FW: Does the cannabinoid dro - nabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial. BMJ 2004; 329: 253.
-
(2004)
BMJ
, vol.329
, pp. 253
-
-
Svendsen, K.B.1
Jensen, T.S.2
Bach, F.W.3
-
96
-
-
77957567663
-
Effect of dronabinol on central neuropathic pain after spinal cord injury: A pilot study
-
Rintala DH, Fiess RN, Tan G, Holmes SA, Bruel BM: Effect of dronabinol on central neuropathic pain after spinal cord injury: a pilot study. Am J Phys Med Rehabil 2010; 89: 840-8.
-
(2010)
Am J Phys Med Rehabil
, vol.89
, pp. 840-848
-
-
Rintala, D.H.1
Fiess, R.N.2
Tan, G.3
Holmes, S.A.4
Bruel, B.M.5
-
97
-
-
0345669751
-
A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms
-
Wade DT, Robson P, House H, Makela P, Aram J: A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms. Clin Rehabil 2003; 17: 18-26.
-
(2003)
Clin Rehabil
, vol.17
, pp. 18-26
-
-
Wade, D.T.1
Robson, P.2
House, H.3
Makela, P.4
Aram, J.5
-
98
-
-
9244223576
-
Efficacy of two cannabis based medicinal extracts for relief of central neuropathic pain from brachial plexus avulsion: Results of a randomised controlled trial
-
Berman JS, Symonds C, Birch R: Efficacy of two cannabis based medicinal extracts for relief of central neuropathic pain from brachial plexus avulsion: results of a randomised controlled trial. Pain 2004; 112: 299-306.
-
(2004)
Pain
, vol.112
, pp. 299-306
-
-
Berman, J.S.1
Symonds, C.2
Birch, R.3
-
99
-
-
33750618230
-
Low dose treatment with the synthetic cannabinoid Nabilone significantly reduces spasticityrelated pain : A double-blind placebo-controlled cross-over trial
-
Wissel J, Haydn T, Müller J, et al.: Low dose treatment with the synthetic cannabinoid Nabilone significantly reduces spasticityrelated pain : a double-blind placebo-controlled cross-over trial. J Neurol 2006; 253: 1337-41.
-
(2006)
J Neurol
, vol.253
, pp. 1337-1341
-
-
Wissel, J.1
Haydn, T.2
Müller, J.3
-
100
-
-
38949107918
-
Comparison of analgesic effects and patient tolerability of nabilone and dihydrocodeine for chronic neuropathic pain: Randomised, crossover, double blind study
-
Frank B, Serpell MG, Hughes J, Matthews JN, Kapur D: Comparison of analgesic effects and patient tolerability of nabilone and dihydrocodeine for chronic neuropathic pain: randomised, cross - over, double blind study. BMJ 2008; 336: 199-201.
-
(2008)
BMJ
, vol.336
, pp. 199-201
-
-
Frank, B.1
Serpell, M.G.2
Hughes, J.3
Matthews, J.N.4
Kapur, D.5
-
101
-
-
25444530723
-
Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis
-
Rog DJ, Nurmikko TJ, Friede T, Young CA: Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis. Neurology 2005; 65: 812-9.
-
(2005)
Neurology
, vol.65
, pp. 812-819
-
-
Rog, D.J.1
Nurmikko, T.J.2
Friede, T.3
Young, C.A.4
-
102
-
-
36348982602
-
Sativex successfully treats neuropathic pain characterised by allodynia: A randomised, double-blind, placebo-controlled clinical trial
-
Nurmikko TJ, Serpell MG, Hoggart B, Toomey PJ, Morlion BJ, Haines D: Sativex successfully treats neuropathic pain characterised by allodynia: a randomised, double-blind, placebo-controlled clinical trial. Pain 2007; 133: 210-20.
-
(2007)
Pain
, vol.133
, pp. 210-220
-
-
Nurmikko, T.J.1
Serpell, M.G.2
Hoggart, B.3
Toomey, P.J.4
Morlion, B.J.5
Haines, D.6
-
103
-
-
74249110995
-
Randomised Placebo Controlled Double Blind Clinical Trial of Cannabis Based Medicinal Product (Sativex) in Painful Diabetic Neuropathy: Depression is a Major Confounding Factor
-
Selvarajah D, Gandhi R, Emery CJ, Tesfaye S: Randomised Placebo Controlled Double Blind Clinical Trial of Cannabis Based Medicinal Product (Sativex) in Painful Diabetic Neuropathy: Depression is a Major Confounding Factor. Diabetes Care 2010; 33: 128-30.
-
(2010)
Diabetes Care
, vol.33
, pp. 128-130
-
-
Selvarajah, D.1
Gandhi, R.2
Emery, C.J.3
Tesfaye, S.4
-
104
-
-
33847013770
-
Cannabis in painful HIV-associated sensory neuropathy: A randomized placebo-controlled trial
-
Abrams DI, Jay CA, Shade SB, et al.: Cannabis in painful HIV-associated sensory neuropathy: A randomized placebo-controlled trial. Neurology 2007; 68: 515-21.
-
(2007)
Neurology
, vol.68
, pp. 515-521
-
-
Abrams, D.I.1
Jay, C.A.2
Shade, S.B.3
-
105
-
-
44249115281
-
A randomized, placebocontrolled, crossover trial of cannabis cigarettes in neuropathic pain
-
Wilsey B, Marcotte T, Tsodikov A, et al.: A randomized, placebocontrolled, crossover trial of cannabis cigarettes in neuropathic pain. J Pain 2008; 9: 506-21.
-
(2008)
J Pain
, vol.9
, pp. 506-521
-
-
Wilsey, B.1
Marcotte, T.2
Tsodikov, A.3
-
106
-
-
58149463198
-
Smoked medicinal cannabis for neuropathic pain in HIV: A randomized, crossover clinical trial
-
Ellis RJ, Toperoff W, Vaida F, et al.: Smoked medicinal cannabis for neuropathic pain in HIV: a randomized, crossover clinical trial. Neuropsychopharmacology 2009; 34: 672-80.
-
(2009)
Neuropsychopharmacology
, vol.34
, pp. 672-680
-
-
Ellis, R.J.1
Toperoff, W.2
Vaida, F.3
-
107
-
-
77958035149
-
Smoked cannabis for chronic neuropathic pain: A randomized controlled trial
-
Ware MA, Wang T, Shapiro S, et al.: Smoked cannabis for chronic neuropathic pain: a randomized controlled trial. CMAJ 2010; 182: 694-701.
-
(2010)
CMAJ
, vol.182
, pp. 694-701
-
-
Ware, M.A.1
Wang, T.2
Shapiro, S.3
-
108
-
-
0141593561
-
Analgesic effect of the synthetic cannabinoid CT-3 on chronic neuropathic pain: A randomized controlled trial
-
Karst M, Salim K, Burstein S, Conrad I, Hoy L, Schneider U: Analgesic effect of the synthetic cannabinoid CT-3 on chronic neuropathic pain: a randomized controlled trial. JAMA 2003; 290: 1757-6.
-
(2003)
JAMA
, vol.290
, pp. 1757-1766
-
-
Karst, M.1
Salim, K.2
Burstein, S.3
Conrad, I.4
Hoy, L.5
Schneider, U.6
-
110
-
-
0016527783
-
The analgesic properties of delta-9-tetrahydrocannabinol and codeine
-
Noyes R, Brunk ST, Avery DH, Canter A: The analgesic properties of delta-9-tetrahydrocannabinol and codeine. Clin Pharmacol Ther 1975; 18: 84-9.
-
(1975)
Clin Pharmacol Ther
, vol.18
, pp. 84-89
-
-
Noyes, R.1
Brunk, S.T.2
Avery, D.H.3
Canter, A.4
-
111
-
-
75949093107
-
Multicenter, double-blind, randomized, placebo- controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD Extract and THC extract in patients with intractable cancer-related pain
-
Johnson JR, Burnell-Nugent M, Lossignol D, Ganae-Motan ED, Potts R, Fallon MT: Multicenter, double-blind, randomized, placebo- controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD Extract and THC extract in patients with intractable cancer-related pain. J Pain Symptom Manage 2010; 39: 167-79.
-
(2010)
J Pain Symptom Manage
, vol.39
, pp. 167-179
-
-
Johnson, J.R.1
Burnell-Nugent, M.2
Lossignol, D.3
Ganae-Motan, E.D.4
Potts, R.5
Fallon, M.T.6
-
112
-
-
0018090510
-
Effect of a nitrogen analog of tetrahydrocannabinol on cancer pain
-
Staquet M, Gantt C, Machin D: Effect of a nitrogen analog of tetrahydrocannabinol on cancer pain. Clin Pharmacol Ther 1978; 23: 397-401.
-
(1978)
Clin Pharmacol Ther
, vol.23
, pp. 397-401
-
-
Staquet, M.1
Gantt, C.2
MacHin, D.3
-
113
-
-
0018145394
-
Effect of benzopyranoperidine, a delta-9-THC congener, on pain
-
Jochimsen PR, Lawton RL, VerSteeg K, Noyes Jr R: Effect of benzopyranoperidine, a delta-9-THC congener, on pain. Clin Pharmacol Ther 1978; 24: 223-7.
-
(1978)
Clin Pharmacol Ther
, vol.24
, pp. 223-227
-
-
Jochimsen, P.R.1
Lawton, R.L.2
Versteeg, K.3
Noyes Jr., R.4
-
114
-
-
29844435136
-
Preliminary assessment of the efficacy, tolerability and safety of a cannabisbased medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis
-
Blake DR, Robson P, Ho M, Jubb RW, McCabe CS: Preliminary assessment of the efficacy, tolerability and safety of a cannabisbased medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis. Rheumatology 2006; 45: 50-2.
-
(2006)
Rheumatology
, vol.45
, pp. 50-52
-
-
Blake, D.R.1
Robson, P.2
Ho, M.3
Jubb, R.W.4
McCabe, C.S.5
-
116
-
-
76249123626
-
The effects of nabi - Lone on sleep in fibromyalgia: Results of a randomized controlled trial
-
Ware MA, Fitzcharles MA, Joseph L, Shir Y: The effects of nabi - lone on sleep in fibromyalgia: results of a randomized controlled trial. Anesth Analg 2010; 110: 604-10.
-
(2010)
Anesth Analg
, vol.110
, pp. 604-610
-
-
Ware, M.A.1
Fitzcharles, M.A.2
Joseph, L.3
Shir, Y.4
-
117
-
-
39549091694
-
Efficacy of dronabinol as an adjuvant treatment for chronic pain patients on opioid therapy
-
Narang S, Gibson D, Wasan AD, et al.: Efficacy of dronabinol as an adjuvant treatment for chronic pain patients on opioid therapy. J Pain 2008; 9: 254-64.
-
(2008)
J Pain
, vol.9
, pp. 254-264
-
-
Narang, S.1
Gibson, D.2
Wasan, A.D.3
-
118
-
-
2342613658
-
Initial experiences with medicinal extracts of cannabis for chronic pain: Results from 34 'N of 1' studies
-
Notcutt W, Price M, Miller R, et al.: Initial experiences with medicinal extracts of cannabis for chronic pain: results from 34 'N of 1' studies. Anaesthesia 2004; 59: 440-52.
-
(2004)
Anaesthesia
, vol.59
, pp. 440-452
-
-
Notcutt, W.1
Price, M.2
Miller, R.3
-
119
-
-
33751425461
-
Evaluation of herbal cannabis characteristics by medical users: A randomized trial
-
Ware MA, Ducruet T, Robinson AR: Evaluation of herbal cannabis characteristics by medical users: a randomized trial. Harm Reduct J 2006; 3: 32.
-
(2006)
Harm Reduct J
, vol.3
, pp. 32
-
-
Ware, M.A.1
Ducruet, T.2
Robinson, A.R.3
-
120
-
-
33746332378
-
Nutzen einer Add-On-Therapie mit dem synthetischen Cannabinomimetikum Nabilone bei Patienten mit chronischen Schmerzzuständen - eine randomisierte kontrollierte Studie
-
Pinsger M, Schimetta W, Volc D, Hiermann E, Riederer F, Polz W: Nutzen einer Add-On-Therapie mit dem synthetischen Cannabinomimetikum Nabilone bei Patienten mit chronischen Schmerzzuständen - eine randomisierte kontrollierte Studie. Wien Klin Wochenschr 2006; 118: 327-35.
-
(2006)
Wien Klin Wochenschr
, vol.118
, pp. 327-335
-
-
Pinsger, M.1
Schimetta, W.2
Volc, D.3
Hiermann, E.4
Riederer, F.5
Polz, W.6
-
121
-
-
0017349888
-
Effects of intravenous tetrahydrocannabinol on experimental and surgical pain: Psychological correlates of the analgesic response
-
Raft D, Gregg J, Ghia J, Harris L: Effects of intravenous tetrahydrocannabinol on experimental and surgical pain: psychological correlates of the analgesic response. Clin Pharmacol Ther 1977; 21: 26-33.
-
(1977)
Clin Pharmacol Ther
, vol.21
, pp. 26-33
-
-
Raft, D.1
Gregg, J.2
Ghia, J.3
Harris, L.4
-
122
-
-
0142227167
-
Lack of analgesic efficacy of oral delta-9-tetrahydrocannabinol in postoperative pain
-
Buggy DJ, Toogood L, Maric S, Sharpe P, Lambert DG, Rowbotham DJ: Lack of analgesic efficacy of oral delta-9-tetrahydrocannabinol in postoperative pain. Pain 2003; 106: 169-72.
-
(2003)
Pain
, vol.106
, pp. 169-172
-
-
Buggy, D.J.1
Toogood, L.2
Maric, S.3
Sharpe, P.4
Lambert, D.G.5
Rowbotham, D.J.6
-
123
-
-
33646235388
-
Delta-9-tetrahydrocannabinol and the opioid receptor agonist piritramide do not act synergistically in postoperative pain
-
Seeling W, Kneer L, Buchele B, et al.: Delta-9-tetrahydrocannabinol and the opioid receptor agonist piritramide do not act synergistically in postoperative pain. Anaesthesist 2006; 55: 391-400.
-
(2006)
Anaesthesist
, vol.55
, pp. 391-400
-
-
Seeling, W.1
Kneer, L.2
Buchele, B.3
-
124
-
-
33646769573
-
A multicenter dose-escalation study of the analgesic and adverse effects of an oral cannabis extract (Cannador) for postoperative pain management
-
Holdcroft A, Maze M, Dore C, Tebbs S, Thompson S: A multicenter dose-escalation study of the analgesic and adverse effects of an oral cannabis extract (Cannador) for postoperative pain management. Anesthesiology 2006; 104: 1040-6.
-
(2006)
Anesthesiology
, vol.104
, pp. 1040-1046
-
-
Holdcroft, A.1
Maze, M.2
Dore, C.3
Tebbs, S.4
Thompson, S.5
-
125
-
-
33748868111
-
Effects of nabilone, a synthetic cannabinoid, on postoperative pain
-
Beaulieu P: Effects of nabilone, a synthetic cannabinoid, on postoperative pain. Can J Anaesth 2006; 53: 769-75.
-
(2006)
Can J Anaesth
, vol.53
, pp. 769-775
-
-
Beaulieu, P.1
-
126
-
-
0019605641
-
Evaluation of intramuscular levonantradol and placebo in acute postoperative pain
-
Jain AK, Ryan JR, McMahon FG, Smith G: Evaluation of intramuscular levonantradol and placebo in acute postoperative pain. J Clin Pharmacol 1981; 21(suppl 8-9): 320-6.
-
(1981)
J Clin Pharmacol
, vol.21
, Issue.SUPPL. 8 AND 9
, pp. 320-326
-
-
Jain, A.K.1
Ryan, J.R.2
McMahon, F.G.3
Smith, G.4
-
127
-
-
0019492496
-
A study of levonantradol, a cannabinol derivative, for analgesia in post operative pain
-
Kantor TG, Hopper M: A study of levonantradol, a cannabinol derivative, for analgesia in post operative pain. Pain 1981; (suppl): S37.
-
(1981)
Pain
, Issue.SUPPL.
-
-
Kantor, T.G.1
Hopper, M.2
-
128
-
-
80052718419
-
A randomized, controlled study to investigate the analgesic efficacy of single doses of the cannabinoid receptor-2 agonist GW842166, ibuprofen or placebo in patients with acute pain following third molar tooth extraction
-
Ostenfeld T, Price J, Albanese M, et al.: A randomized, controlled study to investigate the analgesic efficacy of single doses of the cannabinoid receptor-2 agonist GW842166, ibuprofen or placebo in patients with acute pain following third molar tooth extraction. Clin J Pain 2011; 27: 668-76.
-
(2011)
Clin J Pain
, vol.27
, pp. 668-676
-
-
Ostenfeld, T.1
Price, J.2
Albanese, M.3
-
129
-
-
33750037938
-
The effect of cannabis on urge incontinence in patients with multiple sclerosis: A multicentre, randomised placebo- controlled trial (CAMS-LUTS)
-
Freeman RM, Adekanmi O, Waterfield MR, Waterfield AE, Wright D, Zajicek J: The effect of cannabis on urge incontinence in patients with multiple sclerosis: a multicentre, randomised placebo- controlled trial (CAMS-LUTS). Int Urogynecol J Pelvic Floor Dysfunct 2006; 17: 636-41.
-
(2006)
Int Urogynecol J Pelvic Floor Dysfunct
, vol.17
, pp. 636-641
-
-
Freeman, R.M.1
Adekanmi, O.2
Waterfield, M.R.3
Waterfield, A.E.4
Wright, D.5
Zajicek, J.6
-
130
-
-
4344585483
-
An open-label pilot study of cannabis-based extracts for bladder dysfunction in advanced multiple sclerosis
-
Brady CM, DasGupta R, Dalton C, Wiseman OJ, Berkley KJ, Fowler CJ: An open-label pilot study of cannabis-based extracts for bladder dysfunction in advanced multiple sclerosis. Multiple Sclerosis 2004; 10: 425-33.
-
(2004)
Multiple Sclerosis
, vol.10
, pp. 425-433
-
-
Brady, C.M.1
Dasgupta, R.2
Dalton, C.3
Wiseman, O.J.4
Berkley, K.J.5
Fowler, C.J.6
-
131
-
-
78349253181
-
Randomized controlled trial of Sativex to treat detrusor overactivity in multiple sclerosis
-
Kavia RB, De Ridder D, Constantinescu CS, Stott CG, Fowler CJ: Randomized controlled trial of Sativex to treat detrusor overactivity in multiple sclerosis. Mult Scler 2010; 16: 1349-59.
-
(2010)
Mult Scler
, vol.16
, pp. 1349-1359
-
-
Kavia, R.B.1
De Ridder, D.2
Constantinescu, C.S.3
Stott, C.G.4
Fowler, C.J.5
-
132
-
-
0036219901
-
Treatment of Tourette's syndrome with Δ9-tetrahydrocannabinol (THC): A random ized crossover trial
-
Müller-Vahl KR, Schneider U, Koblenz A, et al.: Treatment of Tourette's syndrome with Δ9-tetrahydrocannabinol (THC): a random ized crossover trial. Pharmacopsychiatry 2002; 35: 57-61.
-
(2002)
Pharmacopsychiatry
, vol.35
, pp. 57-61
-
-
Müller-Vahl, K.R.1
Schneider, U.2
Koblenz, A.3
-
133
-
-
0038710735
-
Δ9-tetrahydrocannabinol (THC) is effective in the treatment of tics in Tourette syndrome: a 6-week randomized trial
-
Müller-Vahl KR, Schneider U, Prevedel H, et al.: Δ9-tetrahydrocannabinol (THC) is effective in the treatment of tics in Tourette syndrome: a 6-week randomized trial. J Clin Psychiatry 2003; 64: 459-65.
-
(2003)
J Clin Psychiatry
, vol.64
, pp. 459-465
-
-
Müller-Vahl, K.R.1
Schneider, U.2
Prevedel, H.3
-
134
-
-
0001291621
-
The effects of the cannabinoid receptor agonist nabilone on L-DOPA induced dyskinesia in patients with idiopathic Parkinson's disease (PD)
-
Sieradzan KA, Fox SH, Dick J, Brotchie JM: The effects of the cannabinoid receptor agonist nabilone on L-DOPA induced dyskinesia in patients with idiopathic Parkinson's disease (PD). Movement Disorders 1998; 13(Suppl 2): 29.
-
(1998)
Movement Disorders
, vol.13
, Issue.SUPPL. 2
, pp. 29
-
-
Sieradzan, K.A.1
Fox, S.H.2
Dick, J.3
Brotchie, J.M.4
-
135
-
-
67649265233
-
Synthetic delta-9-tetrahydrocannabinol (dronabinol) can improve the symptoms of schizophrenia
-
Schwarcz G, Karajgi B, McCarthy R: Synthetic delta-9-tetrahydrocannabinol (dronabinol) can improve the symptoms of schizophrenia. J Clin Psychopharmacol 2009; 29: 255.
-
(2009)
J Clin Psychopharmacol
, vol.29
, pp. 255
-
-
Schwarcz, G.1
Karajgi, B.2
McCarthy, R.3
-
136
-
-
78649784793
-
Improvement in refractory psychosis with dronabinol: Four case reports
-
Schwarcz G, Karajgi B: Improvement in refractory psychosis with dronabinol: four case reports. J Clin Psychiatry 2010; 71: 1552-3.
-
(2010)
J Clin Psychiatry
, vol.71
, pp. 1552-1553
-
-
Schwarcz, G.1
Karajgi, B.2
-
137
-
-
0017095185
-
Clinical studies of cannabis tolerance and dependence
-
Jones RT, Benowitz N, Bachman J: Clinical studies of cannabis tolerance and dependence. Ann N Y Acad Sci 1976; 282: 221-39.
-
(1976)
Ann N y Acad Sci
, vol.282
, pp. 221-239
-
-
Jones, R.T.1
Benowitz, N.2
Bachman, J.3
-
138
-
-
0018111446
-
Biological aspects of cannabis use
-
Stefanis C: Biological aspects of cannabis use. NIDA Res Monogr 1978; 19: 149-78.
-
(1978)
NIDA Res Monogr
, vol.19
, pp. 149-178
-
-
Stefanis, C.1
-
139
-
-
0034943318
-
Tetrahydrocannabinol zur Therapie chronischer Schmerzen
-
Elsner F, Radbruch L, Sabatowski R: Tetrahydrocannabinol zur Therapie chronischer Schmerzen. Schmerz 2001; 15: 200-4.
-
(2001)
Schmerz
, vol.15
, pp. 200-204
-
-
Elsner, F.1
Radbruch, L.2
Sabatowski, R.3
-
140
-
-
84861456223
-
Reversible and regionally selective down regulation of brain cannabinoid CB(1) receptors in chronic daily cannabis smokers
-
Hirvonen J, Goodwin RS, Li CT, et al.: Reversible and regionally selective down regulation of brain cannabinoid CB(1) receptors in chronic daily cannabis smokers. Molecular Psychiatry 2012; 17, 642-49.
-
(2012)
Molecular Psychiatry
, vol.17
, pp. 642-649
-
-
Hirvonen, J.1
Goodwin, R.S.2
Li, C.T.3
-
141
-
-
21044453748
-
The effect of nabilone on neuropsychological functions related to driving ability: An extended case series
-
Kurzthaler I, Bodner T, Kemmler G, et al.: The effect of nabilone on neuropsychological functions related to driving ability: an extended case series. Hum Psychopharmacol 2005; 20: 291-3.
-
(2005)
Hum Psychopharmacol
, vol.20
, pp. 291-293
-
-
Kurzthaler, I.1
Bodner, T.2
Kemmler, G.3
-
142
-
-
82955203477
-
Cannabinoids improve driving ability in a Tourette's patient
-
Brunnauer A, Segmiller FM, Volkamer T, Laux G, Müller N, Dehning S: Cannabinoids improve driving ability in a Tourette's patient. Psychiatry Res 2011; 190: 382.
-
(2011)
Psychiatry Res
, vol.190
, pp. 382
-
-
Brunnauer, A.1
Segmiller, F.M.2
Volkamer, T.3
Laux, G.4
Müller, N.5
Dehning, S.6
|